AI In Drug Development: FDA Wants To Know How To Assure Data Integrity, Transparency, Reliability

US FDA asks stakeholders how they are addressing bias, reproducibility and data privacy in application of AI/ML. Discussion paper describes current and potential uses of artificial intelligence and machine learning in drug development.